180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
4
Frequently Asked Questions
What is Market Cap of 180 Life Sciences Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. 180 Life Sciences Corp market cap is $962,400.00.
What is the 52-week high for 180 Life Sciences Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. 180 Life Sciences Corp 52 week high is $27.93 as of September 15, 2025.
What is the 52-week low for 180 Life Sciences Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. 180 Life Sciences Corp 52 week low is $1.33 as of September 15, 2025.
What is 180 Life Sciences Corp stock price today?
180 Life Sciences Corp stock price today is $1.83.
What was 180 Life Sciences Corp stock price yesterday?
180 Life Sciences Corp stock price yesterday was $1.77.
What is the PE ratio of 180 Life Sciences Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. 180 Life Sciences Corp’s P/E ratio is -0.03.
What is the Price-to-Book ratio of 180 Life Sciences Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. 180 Life Sciences Corp P/B ratio is -7.5352.
What is 180 Life Sciences Corp's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. 180 Life Sciences Corp's EBITDA is -0.11.
What is the 50-day moving average of 180 Life Sciences Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. 180 Life Sciences Corp 50-day moving average is $2.85.
How many employess does 180 Life Sciences Corp has?
